Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients

MH Karimi, M Motazedian, B Geramizadeh, S Nikeghbalian, R Yaghobi, F Abedi, M Hossin Aghdaee, N Azarpira, M Arabpour, Z Malekpour, M Namayandeh


Background: Co-stimulatory molecules play a critical role in regulating T-cell function during CMV infection after liver transplantation.

Objective: To investigate the relationship between the polymorphisms of the co-stimulatory genes and the susceptibility to CMV infection after liver transplantation.

Methods: Single nucleotide polymorphisms (SNPs) in PD-1 gene (PD1.1 A/G, PD1.3 A/G, PD1.9 C/T) ICOS (-693 A/G, 1720 C/T), CTLA-4 gene (?318 C/T, 1722 T/C, 1661 A/G, 49 A/G) and CD28 (+17 C/T) were analyzed by PCR-RFLP in 70 liver transplant patients. CMV infection was determined in these patients by antigenemia test.

Results: CTLA-4 49G showed significant association with CMV infection (p=0.03, OR=3.82, 95% CI: 0–3.5; p=0.01, OR=004, 95% CI: 0–1.3). G and T alleles in CTLA-4 gene (?318 C/T and 1661 A/G) (p=0.03, OR=0, 95% CI: 0–3.5; p=0.01, OR=0.04, 95% CI: 0–1.3) were significantly higher in CMV-infected rejector group.

Conclusion: CTLA-4 have significant role in CMV pathogenesis and rejection among CMV-positive liver transplant patients.


CMV; Transplant recipient; polymorphisms; Liver; Rejection; pathogenesis

Full Text:


Copyright (c)

 pISSN: 2008-6482
 eISSN: 2008-6490


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License